Coral Genomics
San Francisco
About Coral Genomics
Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.7M
- Funding stage: Seed
- Last round: Grant (Jan 2021)
- Website: coralgenomics.com
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/coral-genomics-12998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.